Luliconazole microbiology: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Luliconazole}} {{CMG}}; {{AE}} {{AZ}} ==Microbiology== ===Mechanism of Action=== Luliconazole is an antifungal that belongs to the azole class. Although the exact...")
 
No edit summary
 
Line 10: Line 10:
To date, a mechanism of resistance to luliconazole has not been described.
To date, a mechanism of resistance to luliconazole has not been described.


LUZU Cream, 1% has been shown to be active against most isolates of the following fungi, both in vitro and in clinical infections as described in the INDICATIONS AND USAGE section:
LUZU Cream, 1% has been shown to be active against most isolates of the following fungi, both in vitro and in clinical infections as described in the indications and usage section:


Tricophyton rubrum
*:'''[[Tricophyton]] rubrum'''
Epidermophyton floccosum<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = LUZU (LULICONAZOLE) CREAM [MEDICIS PHARMACEUTICAL CORP.] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a7016010-ce43-4c09-8d21-aeb697ffed31 | publisher =  | date =  | accessdate =  }}</ref>
 
*:'''[[Epidermophyton]] floccosum'''<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = LUZU (LULICONAZOLE) CREAM [MEDICIS PHARMACEUTICAL CORP.] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a7016010-ce43-4c09-8d21-aeb697ffed31 | publisher =  | date =  | accessdate =  }}</ref>


==References==
==References==

Latest revision as of 15:35, 8 January 2014

Luliconazole
LUZU® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Adverse Reactions
Drug Interactions
Dosage and Administration
Clinical Studies
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

Microbiology

Mechanism of Action

Luliconazole is an antifungal that belongs to the azole class. Although the exact mechanism of action against dermatophytes is unknown, luliconazole appears to inhibit ergosterol synthesis by inhibiting the enzyme lanosterol demethylase. Inhibition of this enzyme’s activity by azoles results in decreased amounts of ergosterol, a constituent of fungal cell membranes, and a corresponding accumulation of lanosterol.

Mechanism of Resistance

To date, a mechanism of resistance to luliconazole has not been described.

LUZU Cream, 1% has been shown to be active against most isolates of the following fungi, both in vitro and in clinical infections as described in the indications and usage section:

References

  1. "LUZU (LULICONAZOLE) CREAM [MEDICIS PHARMACEUTICAL CORP.]".

Adapted from the FDA Package Insert.